• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic secures Health Canada license for MiniMed 630G system

October 21, 2016 By Sarah Faulkner

Medtronic Minimed 630gMedtronic (NYSE:MDT) subsidiary Medtronic Canada said today that it landed a license with Health Canada for its MiniMed 630G insulin pump system for patients with diabetes mellitus.

The Fridley, Minn.-based company said it interviewed more than 1,000 diabetes patients to better understand the features they look for in an insulin pump. The final product has a user-friendly pump that is waterproof in up to 12 feet of water for a maximum of 24 hours and features a high-definition screen.

The 630G system integrates continuous glucose monitoring and the company’s SmartGuard tech, which triggers an alarm when the sensor reaches a preset low limit. If the user in unresponsive to the alarm, the device will suspend insulin delivery. The SmartGuard features are the 1st of its kind in Canada, according to Medtronic.

“We are excited to announce the launch of the MiniMed 630G system for Canadians living with diabetes,” director of diabetes & consumer care, Laura Cameron, said in prepared remarks.  “This latest innovation is a step towards Medtronic’s vision of transforming diabetes care and our commitment to providing improved outcomes and an improved user experience for our customers.”

The device will be commercially available in Canada in early 2017. Medtronic announced the US launch of the MiniMed 630G in August and recently won FDA approval for the 1st artificial pancreas.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance Tagged With: Health Canada, Medtronic

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS